Register entry

KAKEN Pharmaceutical Co., LTD

Data as of · How to read this entry

Registered sites
1
Active NDC listings
2
Labeller names
2
Live patents
0
Countries
1
Base
Japan
Authorisation

Registered operations

Analytical testing1Active ingredient (API) manufacture1Labelling1Finished drug manufacture1Packaging1
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
KAKEN Pharmaceutical Co., LTD301 Gensuke, Fujieda-shi, Shizuoka 426-8646, Japan (JPN)Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging3002807376706296951
Catalogue

Drug listings by form and route

2

2 active NDC listings: 1 bulk ingredient, 1 drug for further processing. By marketing category: BULK INGREDIENT 1, DRUG FOR FURTHER PROCESSING 1.

Dosage formNDCs
powder1
solution1
RouteNDCs
Labeller name on the listingNDCs
kaken pharmaceutical co., ltd1
kaken pharmaceutical co., ltd.1
Catalogue

Marketed products

2
BrandGeneric nameForm / routeNDC
-Butenafine Hydrochloridepowder51265-363BULK INGREDIENT
-EFINACONAZOLEsolution51265-541DRUG FOR FURTHER PROCESSING
Compare

Comparable companies in Japan

Enquiry

Common questions

Is KAKEN Pharmaceutical Co., LTD FDA approved?
KAKEN Pharmaceutical Co., LTD holds 1 FDA-registered establishment in Japan. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are KAKEN Pharmaceutical Co., LTD's drugs manufactured?
The FDA register lists Fujieda-shi. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, finished drug manufacture, packaging.
What drugs does KAKEN Pharmaceutical Co., LTD make?
2 products are listed under KAKEN Pharmaceutical Co., LTD in the openFDA NDC Directory, most often as powder; solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.